OKYO Pharma Ltd (NASDAQ:OKYO) is set to present at Biotech Showcase in San Francisco from January 8-10, 2024.
CEO Gary Jacob will lead the presentation on the clinical development status of OK-101 for dry eye disease on January 9th at 9:30 am PST in Room Yosemite-A.
Additionally, the OKYO management team will engage in one-on-one partnering meetings throughout the conference. This event marks an opportunity for OKYO Pharma to showcase its advancements in the quest for effective treatments in these challenging ocular conditions.